Drug recall · March 29, 2017
ATENOLOL Tablets recall
Why: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.
- Lots / codes
Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18
- Quantity
- 9561 bottles
- Company
- Zydus Pharmaceuticals USA Inc, Pennington, NJ
- Distribution
- Nationwide in the USA and Puerto Rico.
- Initiated
- March 6, 2017 · Voluntary: Firm initiated
- Classified
- March 21, 2017
- Reported
- March 29, 2017
- Ended
- November 5, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atenolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.